Skip to main content

Table 2 Patient characteristics

From: Factors affecting health-related quality of life in Thai children with thalassemia

 

N (%)/Mean (SD)

Gender (n = 314)

 

   Male

159 (50.6%)

   Female

155 (49.4%)

Age (years) (n = 315)

10.0 (3.3)

Diagnosis (n = 310)

 

   β-thalassemia/Hb E

165 (53.2%)

   Homozygous β-thalassemia

15 (4.8%)

   Hemoglobin H

130 (42%)

Age at onset of anemia (years)

(n = 270)

3.61 (2.6)

Age at first transfusion (years)

(n = 191)

3.91 (2.8)

Receiving a blood transfusion during the previous 3 months

(n = 245)

 

   Yes

103 (42%)

   No

142 (58%)

Frequency of blood transfusion

(n = 312)

 

   None

146 (46.8%)

   Occasional (1-5 times/year)

58 (18.6%)

   Low (6-12 times/year)

77 (24.7%)

   High (13-22 times/year)

31 (9.9%)

Pre-transfusion Hb level 3 months prior to QOL assessment (g/dL)

(n = 265)

8.04 (1.2)

Serum ferritin level (ng/mL) (n = 127)

2509.9(1903.6)

Iron chelation treatment (n = 314)*

 

   Yes

86 (27.4%)

   No

228 (72.6%)

Complications (n = 314)

 

   Yes

19 (6.1%)

   No

295 (93.9%)

Age at onset of anemia <2 and age at first transfusion <4 years old

(n = 241)

 

   Yes

75 (31.1%)

   No

166 (68.9%)

Having a severe condition** (n = 314)

 

   Yes

113 (36%)

   No

201 (64%)

  1. * Subcutaneous injection treatment
  2. ** Patients whose age at onset <2 and age at first transfusion <4 years, and/or patients diagnosed with homozygous beta-thalassemia, and/or patients with a pre-transfusion Hb level lower than 7 g/dL.